Loading treatments…
Hematology
Daga
$3,000
Har zuwa $80,000 ya danganta da cibiya
Tsawon lokaci na yau da kullum
14–60 days
Hada da gwaje-gwajen kafin tiyata
Asibitocin hadin gwiwa
15
An duba su don bayanan sakamako da takardar shaida
An bincika wannan abun ciki don daidaiton likitanci daga: Dr. Rodina Ainasoa · Marubuciyar Likitanci & Sadarwar Lafiya
Amfani da sel na shina wajen jiyya — haematopoietic, mesenchymal, ko induced pluripotent — don gyarawa, sabuntawa, ko maye gurbin nama mai lalace a cututtukan jini, yanayin degenerative, da wasu cututtukan autoimmune da aka zaɓa.
Ana daidaita al'amarinku da cibiya bisa bayanan sakamako na likitanci, ba talla ba. Muna tsara kowane mataki — daga gwaje-gwajen kafin tiyata zuwa biye-biye bayan jiyya — tare da mai tsara kulawa na musamman.
Maganin Sel Iri (Stem Cell)
Kimar farashin hadin kai daga
ko aiko mana sako a kan WhatsApp
Ba a bukatar alkawari. Ana raba bayananku ne kawai da jam'iyyun da aka amince da su wadanda ke da hannu a hadin kan kulawar ku, bisa ka'idojin sirri da suka shafi.
Daga
$3,000
Har zuwa $80,000 ya danganta da cibiya
Tsawon lokaci na yau da kullum
14–60 days
Hada da gwaje-gwajen kafin tiyata
Hanyoyi
4
Riƙe don ganin hanyoyi
Asibitocin hadin gwiwa
15
An duba su don bayanan sakamako da takardar shaida
Maganin kwayoyin halittar mesenchymal (MSC) don matsalolin kasusuwa da lalacewar gaɓoɓi yana amfani da ko dai kwayoyin halittar mara lafiya da kansa ko kwayoyin halitta daga mai bayarwa. Wanne hanya ce ta dace, idan akwai, shawara ce ta gwani mai cancanta, bisa shaidun da aka buga game da wannan yanayin na musamman — ba zato na gaba ɗaya cewa kwayoyin halitta suna taimakawa kowane yanayi ba, bisa ga Littafin Jagora na Marasa lafiya na ISSCR (International Society for Stem Cell Research).
| Ma'auni | Na Mara lafiya Da Kansa | Daga Mai Bayarwa |
|---|---|---|
| Tushen kwayoyin halitta | Ana tattara kwayoyin halitta (galibi kwayoyin halittar mesenchymal) daga kasusuwan kashi, kitse, ko nama na cibiya na mara lafiya da aka tattara a lokacin haihuwa, sannan a shirya su kafin amfani, bisa ga Mayo Clinic da Cleveland Clinic. | Ana samun kwayoyin halitta daga mai bayarwa kuma a ƙara su a dakin gwaje-gwaje; wannan hanyar ta dogara sosai kan ka'idar ƙera da amincewar hukuma ga takamaiman kayayyakin da ake amfani da su, bisa ga jagorar ISSCR. |
| Haɗarin ƙin karɓar rigakafi | Ƙarancin haɗarin ƙin karɓar rigakafi a ka'idar ilimi, tunda kwayoyin halittar sun fito daga jikin mara lafiya da kansa. | Kayayyakin da aka samu daga mai bayarwa suna da bambancin martanin rigakafi wanda ya dogara da takamaiman tsarin ƙerawa; ya kamata gwani mai kula ya tantance wannan maimakon a ɗauka ba shi da haɗari, bisa ga jagorar ISSCR. |
| Matsayin hukuma | Kulawar hukuma ta bambanta sosai gwargwadon ƙasa da yadda ake sarrafa kwayoyin halittar kaɗan; FDA ta yi gargaɗi sau da yawa cewa yawancin kayayyakin kwayoyin halitta na kansa da ake tallatawa don matsalolin kasusuwa ko lalacewa ba su da amincewar FDA. | Kayayyakin kwayoyin halitta daga mai bayarwa suna buƙatar tsauraran ƙa'idojin ƙera da tsaro; FDA ta ɗauki matakan tilastawa akan asibitocin da ke tallata kayayyakin kwayoyin halitta daga mai bayarwa marasa amincewa. |
| Ƙarfin shaidar asibiti (lalacewar gwiwa a matsayin misali) | Bita na tsari na allurar MSC ta kansa don lalacewar gwiwa sun ba da rahoton ci gaba a jin zafi da aiki idan aka kwatanta da farkon, amma tabbacin shaidar an kimanta shi a matsayin ƙasa zuwa ƙasa sosai saboda ƙananan bincike, bambance-bambance masu yawa, da gwaje-gwajen dogon lokaci masu iyaka, bisa ga bita na tsari da masana suka duba. | Shaidar kayayyakin MSC daga mai bayarwa don matsalolin gaɓoɓi ba ta kai girma kamar ta hanyoyin na kansa ba kuma ta bambanta sosai gwargwadon kayayyaki da bincike, bisa ga littattafan da masana suka duba. |
| Abin da za a tabbatar kafin ci gaba | Ka tambaya musamman wace shaidar asibiti da aka buga ke akwai game da yanayinka na musamman, kuma ka tabbatar da matsayin hukuma na cibiyar da za ta kula da kai ga kayayyakin da ake amfani da su, bisa ga jagorar ISSCR ga marasa lafiya. | Irin wannan tabbatarwa ta shafi, tare da kula na musamman ga takardun ƙera da hukuma na kayayyakin daga mai bayarwa, bisa ga jagorar ISSCR ga marasa lafiya. |
Bayanin da ke ƙasa ya bayyana tsarin gaba ɗaya na maganin kwayoyin halittar mesenchymal don matsalolin kasusuwa/lalacewar gaɓoɓi. Matakan musamman, tushen kwayoyin halitta, da ko wannan magani ya dace kwata-kwata sun dogara da ganewar cutarka da shaidar da aka buga game da yanayinka na musamman, kamar yadda gwani mai kula da kai zai tabbatar.
Tantancewa da tushen kwayoyin halitta
Gwani yana duba ganewar cuta, hoto, da tarihin magani na baya don tantance ko shaidar da aka buga ta goyi bayan maganin MSC don takamaiman yanayin; idan aka ci gaba, ana tattara kwayoyin halitta daga mara lafiya (kasusuwan kashi ko kitse) ko a samo su daga kayayyakin da aka amince da su daga mai bayarwa, bisa ga Mayo Clinic da Cleveland Clinic.
Sarrafawa da shirya a dakin gwaje-gwaje
Ana sarrafa kwayoyin halittar da aka tattara ko samo, a tattara su, a bincika ingancinsu a dakin gwaje-gwaje kafin bayarwa; ka'idar ƙera da ake amfani da ita a nan ita ce ɗaya daga cikin manyan abubuwan da ke bambanta kulawa mai kyau da asibitocin da ba a kula da su ba, bisa ga jagorar ISSCR.
Bayarwa
Ana ba da kwayoyin halittar da aka shirya ta hanyar allura a cikin gaɓa ko naman da aka nufa, yawanci ƙarƙashin jagorancin hoto don sanya daidai; wannan tsari ne na allura, ba tsarin tiyata na na'ura mai sarrafa kansa ba, bisa ga Cleveland Clinic da littattafan kasusuwa da aka buga.
Sa ido da bibiya
Ana sa ido kan marasa lafiya don martani nan take bayan bayarwa, sannan a bi su a cikin makonni da watanni masu zuwa don tantance martani; saboda ingancin shaida yana bambanta gwargwadon yanayin, ya kamata bibiya ta haɗa da tantancewa ta gaskiya na sakamakon da ya dace da wannan ganewar, bisa ga littattafan da masana suka duba.
Ciwo kadan, kumburi, ko zazzabi na wucin gadi a wurin allura ana ba da rahoto akai-akai kuma yawanci yana warware da sauri; wannan shine binciken tsaro da aka rubuta cikin daidaito sosai a cikin nazarce-nazarcen da aka buga, bisa ga bita na tsari da masana suka duba.
Yawancin marasa lafiya suna komawa aiki mai sauƙi na yau da kullum a cikin 'yan kwanaki; gwani mai kula ne ke tsara iyakokin aiki gwargwadon gaɓa da yanayin da ake magani.
Idan martani na magani ya faru, nazarce-nazarcen da aka buga na maganin MSC don lalacewar gwiwa sun ba da rahoton ci gaba a jin zafi da aiki yawanci ana tantance su daga wannan matakin har zuwa watanni 24 na bibiya; ba a tabbatar da martanin kowane mutum ba, bisa ga bita na tsari da masana suka duba.
Bayanan sakamako na dogon lokaci har yanzu wani fanni ne na bincike mai gudana tare da babban bambanci daga bincike zuwa bincike; ya kamata marasa lafiya su tattauna tsammani na gaskiya bisa shaida don yanayinsu na musamman tare da gwani mai kula maimakon ɗauka jadawalin sakamako da aka daidaita, bisa ga jagorar ISSCR.
Tushe: Littafin Jagora na Marasa lafiya na ISSCR (International Society for Stem Cell Research); Mayo Clinic; Cleveland Clinic; bita na tsari da masana suka duba na maganin MSC don lalacewar gwiwa. Warkarwa da sakamakon kowane mutum sun bambanta kuma ba a tabbatar da su ba.
Haɗari da Iyakoki da aka Sani
Tushe: Littafin Jagora na Marasa lafiya na ISSCR (International Society for Stem Cell Research); gargaɗin FDA ga marasa lafiya da masu amfani game da kayayyakin kwayoyin halitta marasa amincewa; bita na tsari da masana suka duba. Babu wani tsari da ba shi da haɗari, kuma shaida ga wannan nau'in magani ta bambanta sosai gwargwadon yanayin; gwani mai kula da kai zai duba yanayinka na musamman.
Nazarin asibiti daga nesa
Ka raba ganewar cutarka, hoto, da tarihin magani na baya. Ƙungiyar tsara mu za ta aika da al'amarinka ga gwani domin farkon tantancewa ko shaidar da aka buga ta goyi bayan maganin kwayoyin halitta don yanayinka na musamman.
Tabbatar da shaida da matsayin hukuma
Kafin a ba da shawarar wata cibiya, muna tabbatar da matsayin hukuma da tushen shaidar asibiti da aka buga don takamaiman kayayyaki da yanayin — daidai da jagorar tsaro na ISSCR ga marasa lafiya na guje wa asibitocin 'yawon shakatawa na kwayoyin halitta' marasa tsari.
Haɗa da asibiti da ƙiyasi
Ana ba da ƙiyasin kuɗi mai haɗa kai wanda ya haɗa da tantancewa, tushen ko sarrafa kwayoyin halitta, tsarin bayarwa, da bibiya kafin ka tafi.
Magani da sa ido
Ana daidaita tafiya, tsarin bayarwa, da sa ido nan da nan bayan tsarin tare da ƙungiyar kula da kai a duk lokacin.
Ci gaba da kulawa bayan dawowa
Ana raba taƙaitaccen bayanin magani da jadawalin bibiya tare da gwani na gida kafin ka koma gida, tare da samuwar daidaitawa ta nesa don ci gaba da sa ido da duk wata tambaya da ta taso.
Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.
| Kasa | Matsakaicin farashi | idan aka kwatanta da mafi araha |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $4,600 | —chevron_right |
🇹🇷 Turkey Istanbul | $20,000 | +335%chevron_right |
🇹🇭 Thailand Bangkok · Phuket · Chiang Mai | $25,000 | +443%chevron_right |
🇺🇸 US | $11,500 | +150% |
Farashi kimantawa ne kuma yana bambanta bisa ga cikakkun bayanan aikin, asibiti, da tsananin yanayin likita. Nemi kimar musamman don al'amarinku.
Faridabad, India
Mafi babbar asibiti mai zaman kansa a Asiya — gadaje 2,600, dakunan tiyata 64, fannonin likitanci 81 a filin kadada 130 a Delhi NCR. An amince da NABH da NABL. Cibiyoyin kwarewa a oncology, tiyata ta zuciya, BMT, dashen gaɓoɓi, kimiyyar jijiya, da IVF.
NABH
NABL800+
Likitoci Kwararru
2,600+
Gadaje
Bengaluru, India
Asibiti ta farko a Indiya da aka gina musamman don oncology ta gaɓoɓi. An sanya ta #1 a Bengaluru da #7 a Indiya (Outlook Health 2025). An amince da JCI, NABH da ESMO — oncology ta tiyata, ta likitanci da ta radiation tare da raka'ar BMT mai keɓe da linac Elekta Versa HD.
NABHNABL64+
Likitoci Kwararru
150+
Gadaje
Gurugram, India
Medanta – The Medicity ita ce asibiti #1 a Indiya (Newsweek World's Best Hospitals 2026), an kafa ta ta likita mai suna a tiyata ta jijiyar zuciya Dr. Naresh Trehan a filin kadada 43 a Sector 38, Gurugram. Cibiyar jagora tana aiki da gadaje 1,391 ciki har da gadajen ICU sama da 270, dakunan tiyata 40, da likitoci masu gogewa sama da 900 a fannonin likitanci sama da 30. Medanta ita ce asibiti mai zaman kansa ta Indiya ɗaya da aka sanya koyaushe a cikin manyan cibiyoyin likitanci 150 a duniya, kuma tana karɓar majinyata ta kasa da kasa sama da 20,000 a shekara daga kasashe sama da 130. Cibiyoyin kwarewa nata sun haɗa kulawa ta zuciya, oncology, kimiyyar jijiya, dashen gaɓoɓi, gastrosciences, da kashi, tare da goyon bayan takardar shaidar JCI, NABH, da NABL.
JCINABHNABL900+
Likitoci Kwararru
1,391+
Gadaje
Gurugram, India
Fortis Memorial Research Institute (FMRI) da ke Sector 44, Gurugram ɗaya ce daga cikin manyan asibitoci na uku a Indiya, mai gadaje sama da 1,000 a fannonin likitanci sama da 40. Gida ga manyan kwararru a neurosurgery, tiyata ta zuciya, oncology, dashen gaɓoɓi, da kashi, FMRI tana da radiosurgery ta CyberKnife, jiyya ta sel ta CAR-T, da cikakken iyawar tiyata ta robot. Asibiti tana karɓar majinyata daga kasashe 118, tare da sashen majinyata ta kasa da kasa mai keɓe yana ba da taimakon biza, masu fassara, sufuri daga filin jirgin sama, da daidaita kulawa daga farko zuwa karshe.
JCINABHNABL400+
Likitoci Kwararru
330+
Gadaje
Samun damar manyan cibiyoyin hematology-oncology masu ba da chemotherapy, jiyya ta targeted, immunotherapy, da jiyya ta sel ta CAR T don leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, da sauran cututtukan jini. Indiya da Isra'ila an san su a duniya don ƙwarewa ta hematology, suna ba da cibiyoyi da aka amince da JCI da farashi mai raguwa sosai idan aka kwatanta da kasashen Yamma.
Daga
$12,000
kwana 21–90
Nemo jiyya mai waraka don cutar sickle cell da thalassemia mai girma ta hanyar dashen ƙudan ƙashi, kazalika da sarrafa cuta ƙwararru ciki har da jiyya ta hydroxyurea, shirye-shiryen zub da jini, da chelation. Manyan cibiyoyin hematology a Indiya suna ba da BMT na ɗan'uwan da ya dace da haploidentical don waɗannan matsalolin jini na gado da ƙaramin farashi.
Daga
$15,000
kwana 60–120
Karɓar jiyya mai yuwuwar waraka don aplastic anemia mai tsanani ta hanyar dashen ƙudan ƙashi ko jiyya ta immunosuppressive mai tasiri sosai (IST) tare da anti-thymocyte globulin da cyclosporine. Indiya da Isra'ila suna ba da shirye-shiryen aplastic anemia na ƙargin duniya tare da likitocin hematologist ƙwararru da farashi mai ƙarƙashin farashin Yamma da kashi 60-80%.
Daga
$15,000
kwana 45–100
Samun damar jiyya ta sabuntawa bisa shaida — ciki har da allurai na PRP da jiyya ta sel na shina na mesenchymal — don lalacewar gabbai, lalacewar kwalba, da raunin tendon a cibiyoyi da aka amince ta kasa da kasa. Majinyata suna amfana daga kulawa bisa biologics mafi sabin fasaha da ƙaramin farashi, tare da ɗan gajeren lokacin jira da goyon bayan gyarawa na musamman.
Daga
$1,500
kwana 3–10
Alamun da aka kafa sun haɗa da cututtukan jini (leukemia, lymphoma, myeloma), gazawar kasusuwan kasuwa, cutar sickle cell, da thalassaemia ta hanyar HSCT. Ana amfani da maganin mesenchymal stem cell don zaɓaɓɓun yanayin autoimmune da orthopaedic. CAR T-cell therapy tana kai hari wasu cututtukan jini da suka koma ko suka ƙi amsa.
Kudi bayyananne. Babu alkawari.
CureSureMedico tana karɓar kuɗin tsari bayyananne kuma tsayayye daga majinyaci ko cibiyar biyan kuɗi. Asibiti abokin tarayya ne ke karɓar kuɗin jiyya kai tsaye.
